伽玛刀放射外科治疗Crooke细胞腺瘤患者
本研究纳入5例病理确诊的Crooke细胞腺瘤患者,接受伽玛刀放射外科(GKRS)治疗,中位随访107个月,全部患者肿瘤控制,3例内分泌缓解,3例出现新发或加重的内分泌病,结论认为GKRS似乎是安全且合理有效的治疗选择,但需多中心更大样本研究验证。
要点
- 5例Crooke细胞腺瘤患者接受GKRS后全部实现肿瘤控制。
- 3例患者达到内分泌缓解,中位皮质醇正常化时间12个月。
- 3例出现新发或加重的内分泌病,1例出现颅神经III麻痹。
核心结论
- GKRS似乎是Crooke细胞腺瘤安全且合理有效的治疗选择。
- 需要多中心更大样本研究来验证这些发现。
研究设计与样本
- 本研究纳入5例(2男,3女)病理确诊的Crooke细胞腺瘤患者,在弗吉尼亚大学伽玛刀中心接受GKRS治疗。
- GKRS时中位年龄55岁(范围21-65岁),经蝶窦切除与GKRS之间中位时间间隔5.8个月。
- 中位边缘剂量25 Gy(范围18-25 Gy),中位治疗腺瘤体积3.12 mL,中位随访107个月(范围44-122个月)。
主要发现
- 全部患者实现肿瘤控制。
- 3例患者在末次随访时达到内分泌缓解,停用抗激素分泌药物后皮质醇正常化的中位时间间隔为12个月(范围6-24个月)。
- 3例患者分别于6、15、18个月出现新发或加重的内分泌病。
- 1例患者出现颅神经III麻痹。
- 2例患者分别在GKRS后44个月和50个月需要双侧肾上腺切除术。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要多中心更大样本研究来验证这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Crooke cell adenoma is a very rare subtype of pituitary neoplasm that is known to be clinically aggressive. These tumors can secrete adrenocorticotropic hormone or may be endocrinologically silent. We evaluated the effect of Gamma Knife radiosurgery (GKRS) on endocrine remission and tumor control. MATERIALS AND METHODS: This study comprised 5 patients (2 men, 3 women; median age at GKRS, 55 years [range, 21-65 years]) with pathology-confirmed Crooke cell adenoma treated with GKRS at the Gamma Knife Center of the University of Virginia. The median time interval between transsphenoidal resection and GKRS was 5.8 months. The median margin dose was 25 Gy (range, 18-25 Gy). Median treated adenoma volume was 3.12 mL. Median follow-up was 107 months (range, 44-122 months). RESULTS: Tumor control was achieved in all patients. Three patients achieved endocrine remission at the last follow-up. The median time interval to cortisol normalization when off of anti-hormone secreting medication was 12 months (range, 6-24 months). Newly developed or worsening endocrinopathy occurred in 3 patients at 6, 15, and 18 months, respectively. Cranial nerve III neuropathy developed in 1 patient. Two patients required bilateral adrenalectomy at 44 months and 50 months, respectively, following GKRS. CONCLUSIONS: GKRS appears to be a safe and reasonably effective treatment option for Crooke cell adenoma. Multicenter studies with larger numbers of patients are needed to verify these findings.
引用
- Snyder MH, Shabo L, Lopes MB, et al. Gamma Knife Radiosurgery in Patients with Crooke Cell Adenoma. World Neurosurg. 2020. PMID: 32251826. doi:10.1016/j.wneu.2020.03.152
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。